Fortress Biotech, Inc. balance sheet

At the end of fiscal 2025, Fortress Biotech, Inc. had total assets of $186m, total liabilities of $123m and shareholders' equity of $49.9m. It held $79.4m in cash against $54.5m of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fortress Biotech, Inc.: balance sheet, annual
Fiscal year	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	100	50	98	105	95	66	137	233	306	178	81	57	79	197
Receivables	—	—	0	2	8	5	14	24	23	28	15	10	30	36
Inventory	—	—	0	0	0	1	1	1	10	14	10	14	10	8
Total current assets	100	70	100	110	183	111	156	266	346	230	117	90	124	246
Goodwill	—	—	0	19	19	—	—	—	—	—	—	—	—	—
Total assets	101	89	119	171	246	141	226	333	397	294	168	144	186	317
Accounts payable	0	0	2	—	—	—	—	11	47	57	35	32	14	12
Deferred revenue (current)	—	—	—	0	—	—	—	0	3	1	—	—	—	—
Total current liabilities	11	4	11	57	71	56	46	52	101	128	85	71	50	62
Long-term debt	7	14	24	30	68	84	85	52	43	92	61	58	54	35
Total debt	13	14	24	30	68	84	92	60	60	95	61	58	54	40
Total liabilities	19	19	34	88	125	121	154	136	171	244	166	146	123	111
Shareholders' equity	81	71	57	38	53	2	26	100	109	42	23	23	50	164
Non-controlling interests and other (assets − liabilities − equity)	—	—	27	44	68	18	46	97	117	8	−21	−24	12	42
Shares outstanding	—	—	—	—	—	—	—	—	—	7m	—	—	31m	33m

US$ millions unless shown otherwise. Fiscal quarters.

Fortress Biotech, Inc.: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	11	10	18	16	18	30	25	36
Inventory	12	14	12	13	12	10	9	8
Total current assets	86	90	127	110	119	124	295	246
Total assets	127	144	178	160	181	186	357	317
Accounts payable	34	32	28	20	19	14	14	12
Total current liabilities	70	71	74	58	54	50	103	62
Long-term debt	52	58	56	50	48	54	38	35
Total debt	52	58	56	50	48	54	38	35
Total liabilities	140	146	146	123	116	123	155	111
Shareholders' equity	21	23	22	44	56	50	162	164
Non-controlling interests and other (assets − liabilities − equity)	−34	−24	10	−7	9	12	40	42
Shares outstanding	28m	28m	30m	30m	31m	31m	33m	33m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: FBIO vs RXRX CYTK vs FBIO ABCL vs FBIO

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Fortress Biotech, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Fortress Biotech, Inc.